Crossmark

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

Published Print: 2016-10

Authors

Yamamoto, Brent J.

Shadiack, Annette M.

Carpenter, Sarah

Sanford, Daniel

Henning, Lisa N.

O'Connor, Edward

Gonzales, Nestor

Mondick, John

French, Jonathan

Stark, Gregory V.

Fisher, Alan C.

Casey, Leslie S.

Serbina, Natalya V.
License Information

Version of Record valid from 2016-09-23

Text and Data Mining valid from 2016-10-01
More Information

Publication History

Received: 2016-05-05

Accepted: 2016-07-06

Published: 2016-09-23

Document is current